FDA 510(k) · Zygo Industries
K862766: EPISON, ALERTING SYSTEM FOR EPILEPTICS (Zygo Industries, Inc.)
Zygo Industries, Inc. received FDA 510(k) K862766 for EPISON, ALERTING SYSTEM FOR EPILEPTICS, with a decision date of Mar 13, 1987 (substantially equivalent).
Prescription or OTC: Unknown (no FDA document we parsed states it).
FDA facts
| FDA number | K862766 |
|---|---|
| Pathway | 510(k) |
| Applicant | Zygo Industries, Inc. |
| Device name | EPISON, ALERTING SYSTEM FOR EPILEPTICS |
| Product code | LEL: Device, Sleep Assessment |
| Regulation (21 CFR) | 882.5050 |
| Device class | Class 2 |
| Date received | Jul 22, 1986 |
| Decision date | Mar 13, 1987 |
| Decision | Substantially Equivalent (SESE) |
| 510(k) type | Traditional |
Source: openFDA device 510(k) data, data through Oct 26, 2026.
Indications for use parsed from FDA documents
We could not extract the indications for this record (no summary PDF was processed). Check the FDA record for its summary or statement.
Predicates parsed from FDA documents
No predicate numbers were parsed for this record. The FDA summary, if available, names the predicate.
ChatPPG interpretation
A 510(k) decision of "substantially equivalent" means FDA found the device as safe and effective as a legally marketed predicate. FDA's word for this is cleared, not approved. The clearance covers the device and indications in this submission; it does not extend to other features or versions of the same product that were not part of it. See FDA cleared vs approved.
Product code LEL is "Device, Sleep Assessment", class 2, 21 CFR 882.5050.
Our labels for filtering: claim Sleep, sensor Other. These are heuristics, not FDA fields.